Meir Perez Pugatch, University of Haifa, Israel

'The TRIPS agreement was the most controversial outcome of the Uruguay Round, and is seen by many informed observers as a poisoned chalice for the WTO. Meir Pugatch examines the European side of the lobbying process that produced it. Everyone interested in how business interests affect and even dominate the formation of public policy should read his study.'

• Contents: Preface 1. Introduction 2. The Economic Theory of IPRs (Patents and Trademarks) 3. Economic and Political Explanations for the Emergence of a Stronger International IP System 4. The Advanced Pharmaceutical Industry in Europe and IPRs 5. Core IP Interests and the Organizational Structure of the Advanced Pharmaceutical Industry in Europe 6. TRIPs and Pharmaceuticals 7. Opposition of Developing Countries and LDCs to the TRIPs Pharmaceutical IP Agenda 8. Protecting the International Pharmaceutical IP Agenda of TRIPs: Strategies and Activities of the Advanced Pharmaceutical Industry in Europe between 1995 and 1999 9. The Dynamics of Change within the Framework of IPRs References Annex I: Interviews Index

Meir Perez Pugatch, University of Haifa, Israel

'The TRIPS agreement was the most controversial outcome of the Uruguay Round, and is seen by many informed observers as a poisoned chalice for the WTO. Meir Pugatch examines the European side of the lobbying process that produced it. Everyone interested in how business interests affect and even dominate the formation of public policy should read his study.'

• Contents: Preface 1. Introduction 2. The Economic Theory of IPRs (Patents and Trademarks) 3. Economic and Political Explanations for the Emergence of a Stronger International IP System 4. The Advanced Pharmaceutical Industry in Europe and IPRs 5. Core IP Interests and the Organizational Structure of the Advanced Pharmaceutical Industry in Europe 6. TRIPs and Pharmaceuticals 7. Opposition of Developing Countries and LDCs to the TRIPs Pharmaceutical IP Agenda 8. Protecting the International Pharmaceutical IP Agenda of TRIPs: Strategies and Activities of the Advanced Pharmaceutical Industry in Europe between 1995 and 1999 9. The Dynamics of Change within the Framework of IPRs References Annex I: Interviews Index

Meir Perez Pugatch, University of Haifa, Israel

'The TRIPS agreement was the most controversial outcome of the Uruguay Round, and is seen by many informed observers as a poisoned chalice for the WTO. Meir Pugatch examines the European side of the lobbying process that produced it. Everyone interested in how business interests affect and even dominate the formation of public policy should read his study.'

• Contents: Preface 1. Introduction 2. The Economic Theory of IPRs (Patents and Trademarks) 3. Economic and Political Explanations for the Emergence of a Stronger International IP System 4. The Advanced Pharmaceutical Industry in Europe and IPRs 5. Core IP Interests and the Organizational Structure of the Advanced Pharmaceutical Industry in Europe 6. TRIPs and Pharmaceuticals 7. Opposition of Developing Countries and LDCs to the TRIPs Pharmaceutical IP Agenda 8. Protecting the International Pharmaceutical IP Agenda of TRIPs: Strategies and Activities of the Advanced Pharmaceutical Industry in Europe between 1995 and 1999 9. The Dynamics of Change within the Framework of IPRs References Annex I: Interviews Index